As illustrated in Figure 5, nanotechnology enables a comprehensive and interconnected approach to diabetes management, combining real-time biosensing, smart insulin delivery, regenerative tissue engineering, and AI-guided decision systems. The gene discussed is INS; the disease is diabetes mellitus.